Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Pre-Close Trading Update

28 Apr 2026 07:00

RNS Number : 1040C
Symphony Environmental Tech. PLC
28 April 2026
 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

28 April 2026

 

Symphony Environmental Technologies plc

("Symphony", the "Company" or the "Group")

FY-2025 pre-close trading update and

 

Strong start to FY-2026 - first half profitability

 

Symphony Environmental Technologies plc ("Symphony" or the "Group"); global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable", is pleased to provide the following pre-close trading update for the year ended 31 December 2025 ("FY-2025") and notice of FY-2025 results, together with a trading update for the current year to date.

FY2025 trading update (subject to audit)

Further to the Company's announcement on 17 December 2025, the Board now expects that, as a result of management‑driven strategic change in its Middle East operations, Group revenue for FY-2025 will be higher than previously guided, at approximately £5.7 million, with an adjusted loss before interest, tax, depreciation and amortisation ("adjusted LBITDA") broadly comparable to that incurred in the prior year, at approximately £0.9 million.

Importantly, and as further set out below, sales momentum has not just continued but accelerated during the first four months of FY-2026, running at more than 10 per cent. ahead of the same period last year. Furthermore, margins are also improving due to operational leverage as well as the positive impact of strategic initiatives taken during FY-2025, in particular in the Middle East.

In addition to the above adjusted LBITDA, the following one-off costs were incurred during FY-2025 as well as certain asset provisions will be made to the FY-2025 results:

· Strategic costs of £500,000 primarily in relation to the Middle East but also of certain future corporate initiatives;

· Impairment provision of £468,000 against development costs for the Group's antimicrobial products due to extended South American customer trials and commercial evaluation; and

· Other investment provisions of £107,000.

 

 

The net loss including provisions and strategic costs for FY-2025 is expected to be £2.5 million (FY-2024: £1.3 million).

The Board expects to announce its preliminary results for FY-2025 during the latter half of May.

Outlook

The Board remains focused on margin quality, disciplined cost control and the commercialisation of higher‑value technologies, rather than short‑term volume growth.

That said, it is particularly pleasing that trading in the first four months of 2026 has improved materially. The Group delivered a positive EBITDA in Q1-2026, compared with a loss in the corresponding prior‑year and based on current order patterns, expects to deliver a net profit for H1-2026.

Revenues are currently tracking more than 10 per cent ahead of the same period last year. Confirmed orders have been received across all principal markets, particularly Central America. While the timing of shipments remains subject to customer scheduling and customary operational factors, the Board is encouraged by the visibility and quality of the pipeline now in place, which underpins its confidence in the Group's earnings trajectory.

The Group continues to monitor the evolving geopolitical situation in the Middle East, which to date has not had a material adverse effect on operations.

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. https://www.symphonyenvironmental.com/technologies/biodegradable-plastic/ Instead they will safely biodegrade, leaving no microplastics or toxicity.

 

If they get collected during their programmed life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. 

 

It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDSAIDFIR
Date   Source Headline
28th Dec 200711:06 amRNSResult of EGM
21st Dec 20073:38 pmRNSHolding(s) in Company
19th Dec 200712:41 pmRNSHolding(s) in Company
12th Dec 20074:09 pmRNSHolding(s) in Company
11th Dec 20073:25 pmRNSIssue of Equity
10th Dec 20074:34 pmRNSHolding(s) in Company-Replace
5th Dec 20074:58 pmRNSHolding(s) in Company
4th Dec 20077:01 amRNSIssue of Equity & EGM Notice
3rd Dec 20074:48 pmRNSIssue of Equity & EGM Notice
26th Nov 20073:29 pmRNSTotal Voting Rights
26th Nov 200711:20 amRNSIssue of Options
2nd Oct 20074:16 pmRNSChange of Adviser
28th Sep 20073:50 pmRNSAdditional Listing - Amended
27th Sep 20078:00 amRNSAdditional Listing
27th Sep 20077:01 amRNSInterim Results
17th Aug 20073:37 pmRNSAIM Rule 26
3rd Aug 20077:01 amRNSAppointment of Director
27th Jul 20079:38 amRNSAGM resolutions
27th Jul 20079:00 amRNSAGM Statement
18th Jul 20077:00 amRNSTrading on PLUS
29th Jun 20077:00 amRNSReport & Accounts/AGM Notice
28th Jun 20077:01 amRNS2007 Preliminary Results
30th May 20071:40 pmRNSBusiness Update
9th May 20072:02 pmRNSAdditional Listing
30th Apr 20074:37 pmRNSBus Update & Board Change
7th Mar 20073:59 pmRNSHolding(s) in Company
2nd Mar 200710:51 amRNSHolding(s) in Company
28th Feb 20077:03 amRNSUpdate on placing
27th Feb 20079:57 amRNSResult of EGM
22nd Feb 200710:01 amRNSTrading Update
6th Feb 20077:00 amRNSNotice of EGM
19th Dec 200611:02 amRNSTotal Voting Rights
15th Dec 20067:58 amRNSTrading Statement
13th Nov 20062:16 pmRNSBoard Appointment
13th Oct 20069:28 amRNSTrading Update
25th Sep 20067:01 amRNSInterim Results
20th Sep 200611:07 amRNSNotice of Results
29th Aug 20068:59 amRNSDirectorate Change
21st Aug 20067:00 amRNSSales Agreement
14th Jul 200611:54 amRNSResult of AGM
14th Jul 20069:49 amRNSAGM Statement
21st Jun 200610:04 amRNSNotice of AGM
15th Jun 20067:02 amRNSStrategic Update
22nd May 20067:00 amRNSCaribbean Sales Update
27th Apr 20067:00 amRNSPreliminary Results
24th Apr 20067:01 amRNSNotice of Results (Revised)
4th Apr 20062:12 pmRNSNotice of Results
30th Jan 200611:41 amRNSCourt Award
16th Jan 20068:44 amRNSDirector Shareholding
19th Dec 20053:26 pmRNSCourt Victory

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.